@navamediainsights
We help mental health practices streamline operations, boost patient flow, and lower costs with custom strategies. Let’s grow your impact together.
Nothing here yet.
Oct 16, 2025 · 4 min read · The Scale of the Challenge Mental health disorders are now among the leading causes of disability worldwide. The World Health Organization (WHO) reported in 2025 that up to 90% of people with severe mental health conditions receive no care at all, an...
Join discussion
Oct 16, 2025 · 5 min read · In March 2025, Dr. Nora Volkow a leading voice in addiction research argued that we’re shifting how success is measured: “reduction of drug use” is being advanced as a valid endpoint in treatment trials, not just total abstinence. That’s a humble but...
Join discussion
Oct 16, 2025 · 3 min read · The short answer is: there’s no one-size-fits-all “magic pill.” But the science is evolving, and new possibilities are emerging. Let’s walk through where we are now and where we might be headed. Starting from a recent study: GLP-1 drugs and addiction...
Join discussion
Oct 14, 2025 · 5 min read · In a groundbreaking 2025 randomized trial, researchers found that once-weekly semaglutide a medication originally developed for diabetes and obesity “reduced weekly alcohol craving relative to placebo” and led to measurable declines in alcohol consum...
Join discussion
Oct 14, 2025 · 5 min read · “Now, the FDA accepts reduction in use as a valid clinical outcome” opening new doors for treatments where total abstinence isn’t always immediately realistic. In a small human trial, Ozempic users reduced their alcohol craving and drank significantl...
Join discussion
